CASSIDI LUGO: Open Payments
NPI 1023543915 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,572 in 187 payments from 46 companies in 2025. Trend: 2023 $4,229 · 2024 $8,699 · 2025 $5,572
Food & beverage: $4,381Long term medical supply or device loan: $997Education: $194
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 23 | $1,229 |
| AstraZeneca Pharmaceuticals LP | 13 | $419 |
| PFIZER INC. | 9 | $205 |
| Incyte Corporation | 8 | $201 |
| Eisai Inc. | 8 | $198 |
| Gilead Sciences, Inc. | 8 | $193 |
| Janssen Biotech, Inc. | 8 | $179 |
| E.R. Squibb & Sons, L.L.C. | 9 | $166 |
| GENZYME CORPORATION | 6 | $164 |
| TerSera Therapeutics LLC | 6 | $163 |
Products named: KISQALI, IMFINZI, Lenvima, Trodelvy, Zoladex, ENHERTU, LIBTAYO, Yescarta.
Industry payments across FL — which companies pay providers there.
